Showing results (331-340 of 340) with videos related to

Sort By:
Pageof 34
You have reached the last page of results.This site can display upto 340 results.
The Journal of Surgical Research|October 24, 2007
Student quality-of-life declines during third year surgical clerkshipSteven B Goldin, Monika M Wahi, Osman S Farooq, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 17, 2004
TNFerade biologic, an adenovector with a radiation-inducible promoter, carrying the human tumor necrosis factor alpha gene: a phase I study in patients with solid tumorsNeil Senzer, Sridhar Mani, Alexander Rosemurgy, et al.
Journal of the American College of Surgeons|April 27, 2013
Single-incision laparoscopic cholecystectomy is associated with improved cosmesis scoring at the cost of significantly higher hernia rates: 1-year results of a prospective randomized, multicenter, single-blinded trial of traditional multiport laparoscopic cholecystectomy vs single-incision laparoscopic cholecystectomyJeffrey M Marks, Melissa S Phillips, Roberto Tacchino, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 13, 2008
32P as an adjunct to standard therapy for locally advanced unresectable pancreatic cancer: a randomized trialAlexander Rosemurgy, German Luzardo, Jennifer Cooper, et al.
The Oncologist|July 25, 2024
Treatment of locally advanced pancreatic cancer using localized trans-arterial micro perfusion of gemcitabine: combined analysis of RR1 and RR2Hassan Hatoum, Alexander Rosemurgy, J Augusto Bastidas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Gastrointestinal Endoscopy|January 18, 2012
EUS or percutaneously guided intratumoral TNFerade biologic with 5-fluorouracil and radiotherapy for first-line treatment of locally advanced pancreatic cancer: a phase I/II studyJ Randolph Hecht, James J Farrell, Neil Senzer, et al.
Journal of Pancreatic Cancer|March 31, 2021
A Phase 2 Randomized Placebo-Controlled Adjuvant Trial of GI-4000, a Recombinant Yeast Expressing Mutated RAS Proteins in Patients with Resected Pancreas CancerPeter Muscarella, Tanios Bekaii-Saab, Kristi McIntyre, et al.
Surgical Endoscopy|September 1, 2012
Consensus statement of the consortium for LESS cholecystectomySharona Ross, Alexander Rosemurgy, Michael Albrink, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 24, 2013
Randomized phase III multi-institutional study of TNFerade biologic with fluorouracil and radiotherapy for locally advanced pancreatic cancer: final resultsJoseph M Herman, Aaron T Wild, Hao Wang, et al.
Pageof 34